|
|
.
See Category: Neoplasms
See Header: Cutaneous T-cell lymphoma, unspecified
ICD-10 (CM) Code and Descriptor
|
C84.A5 |
Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
C84A5 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 44.56%
|
29.63%
|
15.29%
|
3.70%
|
1.79%
|
0.72%
|
0.84%
|
0.60%
|
0.24%
|
2.03%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C84.A5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
131
|
131
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
115
|
115
|
|
80053
|
COMPREHEN METABOLIC PANEL |
111
|
111
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
62
|
62
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
60
|
60
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
57
|
57
|
|
96900
|
ACTINOTHERAPY UV LIGHT |
51
|
51
|
|
96413
|
CHEMO IV INFUSION 1 HR |
46
|
46
|
|
83735
|
ASSAY OF MAGNESIUM |
39
|
39
|
|
88185
|
FLOWCYTOMETRY/TC ADD-ON |
39
|
261
|
|
J9042
|
BRENTUXIMAB VEDOTIN INJ |
31
|
3,000
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
29
|
48
|
|
J9315
|
ROMIDEPSIN INJECTION |
29
|
330
|
|
A9552
|
F18 FDG |
28
|
28
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
24
|
34
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
24
|
96
|
|
78816
|
PET IMAGE W/CT FULL BODY |
22
|
22
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
19
|
20
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
17
|
20
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
17
|
17
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C84.A5 related to the following DRG Codes:
820-822
823-825
840-842
974-976
|
